Filter your results
- 1
- 1
- 2
- 2
- 1
- 1
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
sorted by
|
|
Isolation and characterization of two canine melanoma cell lines new models for comparative oncologyBMC Cancer, 2018, 18 (1), pp.1219. ⟨10.1186/s12885-018-5114-y⟩
Journal articles
hal-01972446v1
|
||
Lorlatinib for advanced ALK and ROS1+non-small cell lung cancer (NSCLC): Efficacy and treatment sequences in the IFCT-1803 LORLATU expanded access program (EAP) cohort.Journal of Clinical Oncology, 2020, 38 (15), ⟨10.1200/JCO.2020.38.15_suppl.9615⟩
Journal articles
hal-03036515v1
|